Muhammet Kadri Çolakoğlu1, Erhan Güven2, Gökhan Giray Akgül3, Lütfi Doğan4, Mehmet Ali Gülçelik2. 1. Department of Surgical Oncology, Recep Tayyip Erdogan University School of Medicine, Rize, Turkey. 2. Department of Surgery, University of Health Science, Gülhane Research and Training Hospital, Ankara, Turkey. 3. Department of Surgical Oncology, Mersin University School of Medicine, Mersin, Turkey. 4. Department of Surgery, University of Health Science, Oncology Research and Training Hospital, Ankara, Turkey.
Abstract
OBJECTIVE: Breast cancer subtypes are used as prognostic and predictive factors considering the genomic profile of the disease. This study is designed to investigate the Sentinel Lymph Node (SLN) detection rate in breast cancer for different biological characteristics. MATERIAL AND METHODS: Patients on whom we performed the methylene blue method alone were named as Group I, radiocolloid substance method alone as Group II and both methylene blue and radiocolloid method as Group III. The results of biological tumor characteristics and characteristics of the patients on different SLN biopsy techniques were investigated. RESULTS: The overall SLN detecting success rate was 83.3%. When considered for each group, success rate was 80% for group I, 84.9% for group II and 90.6% for group III. While a success rate of 94.6% was achieved with radiocolloid only in the patients in Luminal A and B subgroup, 90% success rate was achieved in Her2 (+) and triple negative (TN) patients with combined method. CONCLUSION: While successful results could be achieved by using radiocolloid substances alone in patients with Luminal A and B subtypes, combined methods should be used in HER2 (+) and TN patients.
OBJECTIVE: Breast cancer subtypes are used as prognostic and predictive factors considering the genomic profile of the disease. This study is designed to investigate the Sentinel Lymph Node (SLN) detection rate in breast cancer for different biological characteristics. MATERIAL AND METHODS: Patients on whom we performed the methylene blue method alone were named as Group I, radiocolloid substance method alone as Group II and both methylene blue and radiocolloid method as Group III. The results of biological tumor characteristics and characteristics of the patients on different SLN biopsy techniques were investigated. RESULTS: The overall SLN detecting success rate was 83.3%. When considered for each group, success rate was 80% for group I, 84.9% for group II and 90.6% for group III. While a success rate of 94.6% was achieved with radiocolloid only in the patients in Luminal A and B subgroup, 90% success rate was achieved in Her2 (+) and triple negative (TN) patients with combined method. CONCLUSION: While successful results could be achieved by using radiocolloid substances alone in patients with Luminal A and B subtypes, combined methods should be used in HER2 (+) and TN patients.
Entities:
Keywords:
Breast cancer; methylene blue; radiocolloid; sentinel lymph node biopsy
Authors: Anees B Chagpar; Robert C Martin; Charles R Scoggins; David J Carlson; Alison L Laidley; Souzan E El-Eid; Terre Q McGlothin; Robert D Noyes; Phillip B Ley; Todd M Tuttle; Kelly M McMasters Journal: Surgery Date: 2005-07 Impact factor: 3.982
Authors: U Veronesi; G Paganelli; V Galimberti; G Viale; S Zurrida; M Bedoni; A Costa; C de Cicco; J G Geraghty; A Luini; V Sacchini; P Veronesi Journal: Lancet Date: 1997-06-28 Impact factor: 79.321
Authors: Charles E Cox; Elisabeth Dupont; George F Whitehead; Mark D Ebert; Keoni Nguyen; Eric S Peltz; Darian Peckham; Alan Cantor; Douglas S Reintgen Journal: Breast J Date: 2002 Mar-Apr Impact factor: 2.431
Authors: M Koizumi; E Nomura; Y Yamada; T Takiguchi; K Tanaka; M Yoshimoto; M Makita; G Sakamoto; F Kasumi; E Ogata Journal: Nucl Med Commun Date: 2003-06 Impact factor: 1.690
Authors: Nicla La Verde; Elena Biagioli; Chiara Gerardi; Andrea Cordovana; Chiara Casiraghi; Irene Floriani; Elena Bernardin; Gabriella Farina; Serena Di Cosimo; Maria Chiara Dazzani; Giorgio Gherardi Journal: Springerplus Date: 2016-02-03